Pharmacokinetic profile of Oncofid-S after intraperitoneal and intravenous administration in the rat

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 3, 2012, Pages 360-365

  Tringali, Giuseppe ^a   Bettella, Fabio ^b   Greco, Maria Cristina ^a   Campisi, Monica ^b   Renier, Davide ^b   Navarra, Pierluigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Fidia Advanced Biopolymers   (Italy)

Author keywords

hyaluronic acid; intraperitoneal route; intravenous route; rat; SN 38

Indexed keywords

ANTINEOPLASTIC AGENT; ONCOFID S; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SINGLE DRUG DOSE; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CAMPTOTHECIN; HALF-LIFE; HUMANS; HYALURONIC ACID; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; SPLEEN; TISSUE DISTRIBUTION;

EID: 84857048298     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01417.x     Document Type: Article

References (22)

1. Pommier Y,. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006; 6: 789-802. (Pubitemid 44450467)
2. Maruyama M, et al,. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis. Anticancer Res 1999; 19: 4187-4192.
3. Matsui A, et al,. Pharmacology of intraperitoneal CPT-11. Surg Oncol Clin N Am 2003; 12: 795-811. (Pubitemid 36920100)
4. Serafino A, et al,. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis. Curr Cancer Drug Targets 2011; 11: 572-585.
5. Glehen O, et al,. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 2004; 5: 219-228. (Pubitemid 38391217)
6. Maggiori L, Elias D,. Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Eur J Surg Oncol 2010; 36: 599-603.
7. Eriksson S, et al,. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983; 144: 223-228. (Pubitemid 13079334)
8. Fraser JRE, et al,. Uptake of circulating hyaluronic acid by the rat liver. Cellular localisation in situ. Cell Tissue Res 1985; 242: 505-551.
9. Raja RH, et al,. Affinity and distribution of surface and intracellular hyaluronic acid receptors in isolated rat liver endothelial cells. J Biol Chem 1988; 263: 16661-16668. (Pubitemid 18268845)
10. McCourt PA, et al,. Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology 1999; 30: 1276-1286.
11. Engström-Laurent A,. Changes in hyaluronan concentration in tissues and body fluids in disease states. Ciba Found Symp 1989; 143: 233-240.
12. Laurent TC, et al,. Serum hyaluronan as a disease marker. Ann Med 1996; 28: 241-253. (Pubitemid 26191062)
13. Banerji S, et al,. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789-801. (Pubitemid 29234556)
14. Nandi A, et al,. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem 2000; 275: 14939-14948. (Pubitemid 30337210)
15. Zhuo B, et al,. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 2000; 275: 37733-37741.
16. Savani RC, et al,. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001; 276: 36770-36778.
17. Szczepanek K, et al,. Differential binding of hyaluronan on the surface of tissue-specific endothelial cell lines. Acta Biochim Pol 2008; 55: 35-42. (Pubitemid 351468920)
18. Koshiishi I, et al,. CD44 can mediate the adhesion of platelets to hyaluronan. Blood 1994; 84: 390-396. (Pubitemid 24215935)
19. Khan AI, et al,. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 2004; 173: 7594-7601. (Pubitemid 39628201)
20. Guichard S, et al,. Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice. Cancer Chemother Pharmacol 1998; 42: 165-170. (Pubitemid 28267299)
21. Nagahama T, et al,. Intraperitoneal administration of CPT-11 in rats-experimental study for pharmacokinetics. Gan To Kagaru Ryoho 2000; 27: 1866-1969.
22. Maruyama M, et al,. Pharmacokinetic study of the intraperitoneal administration of CPT-11 for patients with peritoneal seedings of gastric and colonic cancers. Gan To Kagaru Ryoho 2001; 28: 1505-1507.